Peer-Assisted Telemedicine for Hepatitis C in People Who Use Drugs: A Randomized Controlled Trial
The Peer TeleHCV treatment model substantially increased HCV treatment initiation and viral clearance compared to EUC. Replication in other rural and low-resource settings could further World Health Organization HCV elimination goals by expanding and decentralizing treatment access for PWUD. Clinical Trials Registration. NCT04798521.
Authors
- Megan C. Herink (ORCID: https://orcid.org/0000-0001-6402-0260)
- Judith Leahy
- Ryan Cook (ORCID: https://orcid.org/0000-0001-8754-995X)
- Jane Babiarz (ORCID: https://orcid.org/0000-0002-4532-9323)
- Hunter Spencer (ORCID: https://orcid.org/0000-0002-5710-1836)
- P. Todd Korthuis (ORCID: https://orcid.org/0000-0001-5556-3597)
- Ann Thomas (ORCID: https://orcid.org/0000-0002-8851-8482)
- Andrew Seaman (ORCID: https://orcid.org/0000-0002-8955-6210)
- Chris Fox (ORCID: https://orcid.org/0000-0001-9480-5704)
- Gillian Leichtling
- Jessica E. Larsen
- Tonhi Gailey
- Joanna Cooper
Institutions
- Oregon State University (US)
- Oregon Health Authority (US)
- Oregon Health & Science University (US)
- Behavioral Health Services (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1093/cid/ciae520
- Citations
- 17
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 6.28